Stocks · Real Estate · REIT - Healthcare Facilities
Universal Health Realty Income Trust UHT
$36.62 +0.52% Close, Oct 2, 2026 · NYSE · Market cap $508.1M
High qualityInexpensive vs sector
Next earnings report: Oct 26, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $148.8M, up 51.0% from a year earlier.
- Net debt is 6.0× EBITDA, a high level of leverage.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Real Estate sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 13%
- EPS growth (TTM, YoY)Bottom 49%
- FCF growth (TTM, YoY)Top 48%
- Revenue growth, 3-year CAGRBottom 38%
- Revenue growth accelerationBottom 41%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 3%
- Gross marginTop 19%
- Operating marginTop 33%
- Cash conversion (OCF / net income)Top 35%
- Accruals (lower is better)Top 27%
- Net debt / EBITDA (lower is better)Bottom 48%
- Interest coverTop 34%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 40%
- Free-cash-flow yieldTop 25%
- EBITDA / enterprise valueTop 37%
- Sales / enterprise valueTop 27%
- P/E vs own 5-year history (lower is better)Top 36%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 38%
- 6-month returnBottom 33%
- 1-year return vs S&P 500Top 49%
- Distance from 52-week highBottom 47%
- Trend checklist (0–4)Bottom 22%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 30%
- Maximum drawdown, 3 yearsTop 29%
- Beta vs S&P 500 (lower is better)Top 20%
- Net debt / EBITDA (lower is better)Bottom 48%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 51.1% | 51.0% | ↓ |
| EPS growth (YoY) | -4.4% | 8.5% | ↑ |
| Gross margin | 94.4% | 76.1% | ↓ |
| Operating margin | 36.2% | 36.5% | ↑ |
| FCF margin | 49.1% | 32.4% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 51.0% | 51.1% | ↓ | Top 13% |
| EPS growth (TTM, YoY) | 8.5% | -4.4% | ↑ | Bottom 49% |
| Gross margin | 76.1% | 94.4% | ↓ | Top 19% |
| Operating margin | 36.5% | 36.2% | ↑ | Top 33% |
| Net margin | 12.9% | 18.2% | ↓ | — |
| Free-cash-flow margin | 32.4% | 49.1% | ↓ | — |
| Return on invested capital | 151.8% | — | Top 3% | |
| Revenue growth, 3-year CAGR | 3.1% | — | Bottom 38% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.50×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -51.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 5.95×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 2.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 8.14%
- Net buyback yield (TTM)
- -0.02%
- Shareholder yield
- 8.12%
- Share count change, 1 year
- +0.2%
- Share count change, 3-year CAGR
- +0.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Average 2-day reaction, last 8
- +0.1%
- Positive 20 days after report
- 2 of 8
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 27, 2026 | — | +1.0% | -0.9% | -5.9% | — |
| Apr 27, 2026 | — | +0.2% | -0.5% | +3.8% | +6.2% |
| Feb 26, 2026 | — | +0.2% | -0.8% | -9.3% | -4.5% |
| Oct 27, 2025 | — | +0.1% | +5.0% | +11.2% | +8.1% |
| Jul 28, 2025 | — | -0.6% | -6.3% | -2.3% | -11.6% |
| Apr 28, 2025 | — | +0.8% | +2.4% | -0.8% | +9.2% |
| Feb 26, 2025 | — | -0.3% | +1.6% | -1.2% | -3.4% |
| Oct 24, 2024 | — | -0.7% | -3.6% | -3.4% | -9.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 27, 2026 | $0.43 | — | — | $25.0M |
| Apr 27, 2026 | $0.36 | — | — | $24.5M |
| Feb 26, 2026 | $0.32 | — | — | $24.5M |
| Oct 27, 2025 | $0.29 | — | — | $25.3M |
| Jul 28, 2025 | $0.33 | — | — | $24.9M |
| Apr 28, 2025 | $0.86 | — | — | $24.5M |
| Feb 26, 2025 | $0.85 | — | — | $24.6M |
| Oct 24, 2024 | $0.82 | — | — | $547,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 26.2× | 31.6× | 19th | Top 40% |
| P/E (forward) | 21.2× | — | — | — |
| EV / EBITDA | 13.7× | — | — | Top 37% |
| EV / Sales | 6.02× | — | — | Top 27% |
| Free-cash-flow yield | 9.50% | — | — | Top 25% |
| Earnings yield | 3.82% | — | — | Top 40% |
P/E over the past five years
Range 6.2× – 37.8× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -6.1%
- Earnings per share growth (TTM)
- +8.5%
- Change in P/E multiple
- +1.7%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -3.9%
- 200-day average slope (20 days)
- -0.3%
- Distance from 50-day average
- -10.6%
- Distance from 200-day average
- -11.4%
- RSI (14)
- 24.5
- Relative volume
- 1.83×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 20.1%
- Volatility vs own 5-year history
- 10th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.28
- Correlation with S&P 500
- 0.17
- Current drawdown from 1-year high
- -20.1%
- Maximum drawdown, 3 years
- -28.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 15, 2021 | Apr 17, 2024 | -56.6% | 778 days | Not yet recovered |
| Dec 15, 2020 | Feb 1, 2021 | -17.6% | 31 days | 24 days (Mar 8, 2021) |
| Oct 2, 2020 | Nov 6, 2020 | -12.1% | 25 days | 2 days (Nov 10, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $508.1M
- P/E (TTM)
- 26.2
- EPS, diluted (TTM)
- $1.40
- Revenue (TTM)
- $148.8M
- Dividend yield
- 8.16%
- 52-week range
- $35.26 – $46.30
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $84.2M | $90.6M | $95.6M | $99.0M | $99.2M |
| Gross profit | $79.8M | $85.5M | $90.3M | $93.5M | $93.6M |
| Operating income | $28.9M | $30.7M | $31.3M | $36.8M | $34.8M |
| Net income | $109.2M | $21.1M | $15.4M | $19.2M | $17.6M |
| EPS (diluted) | $7.92 | $1.53 | $1.11 | $1.39 | $1.27 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.5M | $24.6M | $24.5M | $24.9M | $25.3M | $74.0M | $24.5M | $25.0M |
| Net income | $4.0M | $4.7M | $4.8M | $4.5M | $4.0M | $4.3M | $5.0M | $5.9M |
| EPS (diluted) | $0.29 | $0.34 | $0.34 | $0.32 | $0.29 | $0.32 | $0.36 | $0.43 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $47.7M | $46.8M | $43.5M | $46.9M | $49.1M |
| Capital expenditure | -$13.0M | -$13.6M | $0 | $0 | $0 |
| Free cash flow | $34.7M | $33.2M | $43.5M | $46.9M | $49.1M |
| Dividends paid | -$38.5M | -$39.2M | -$39.8M | -$40.4M | -$41.0M |
| Net share buybacks | $215,000 | $177,000 | $147,000 | -$131,000 | $156,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $6.8M
- Total assets
- $567.1M
- Total liabilities
- $423.2M
- Total debt
- $395.1M
- Net debt
- $388.3M
- Shareholders’ equity
- $143.9M
As of Jun 30, 2026 (filed Aug 7, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 21, 2026 | $0.75 | Sep 30, 2026 |
| Jun 22, 2026 | $0.75 | Jun 30, 2026 |
| Mar 23, 2026 | $0.75 | Mar 31, 2026 |
| Dec 22, 2025 | $0.75 | Dec 31, 2025 |
| Sep 22, 2025 | $0.74 | Sep 30, 2025 |
| Jun 23, 2025 | $0.74 | Jun 30, 2025 |
| Mar 24, 2025 | $0.74 | Mar 31, 2025 |
| Dec 16, 2024 | $0.74 | Dec 31, 2024 |
Short interest
- Shares sold short
- 433,813
- Days to cover
- 4.54
- Change vs previous report
- +7.1%
FINRA short interest, settlement date Sep 15, 2026.